RWS
TEVA icon

Retirement Wealth Solutions’s Teva Pharmaceuticals TEVA Stock Holding History

Retirement Wealth Solutions’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59K Buy
106
+25
+31% +$833 ﹤0.01% 414
2026
Q1 		$2.44K Buy
81
+55
+212% +$1.77K ﹤0.01% 463
2025
Q4 		$812 Buy
26
+9
+53% +$222 ﹤0.01% 612
2025
Q3 		$344 Buy
+17
New +$299 ﹤0.01% 731

Other funds holding TEVA

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Retirement Wealth Solutions's TEVA Position: Q2 2026 in Review

Retirement Wealth Solutions increased its Teva Pharmaceuticals (TEVA) stake by 31% in Q2 2026, buying an estimated $833 and bringing the position to 106 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #414.

Retirement Wealth Solutions first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. 89 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Retirement Wealth Solutions held 106 shares of Teva Pharmaceuticals worth $3.59K as of Q2 2026.
  • Retirement Wealth Solutions bought 25 Teva Pharmaceuticals shares in Q2 2026, an estimated $833.
  • Teva Pharmaceuticals made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q2 2026, its #414 holding.
  • Retirement Wealth Solutions first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 89 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.